BG
LUMO

BlackRock Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

BlackRock Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$102K Buy
1,095
+81
+8% +$9.13K ﹤0.01% 2828
2016
Q3 		$138K Sell
1,014
-208
-17% -$20.7K ﹤0.01% 2747
2016
Q2 		$124K Sell
1,222
-12
-1% -$1.49K ﹤0.01% 2720
2016
Q1 		$203K Buy
1,234
+320
+35% +$64.9K ﹤0.01% 2575
2015
Q4 		$299K Buy
914
+141
+18% +$45.9K ﹤0.01% 2397
2015
Q3 		$249K Buy
773
+151
+24% +$66.3K ﹤0.01% 2456
2015
Q2 		$248K Buy
622
+358
+136% +$152K ﹤0.01% 2519
2015
Q1 		$130K Buy
264
+112
+74% +$43.4K ﹤0.01% 2600
2014
Q4 		$54K Buy
152
+15
+11% +$4.46K ﹤0.01% 2770
2014
Q3 		$26K Buy
137
+55
+67% +$12.1K ﹤0.01% 2745
2014
Q2 		$20K Sell
82
-594
-88% -$121K ﹤0.01% 2773
2014
Q1 		$173K Buy
+676
New +$207K ﹤0.01% 2491

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Group's LUMO Position: Q4 2016 in Review

BlackRock Group increased its Lumos Pharma, Inc. Common Stock (LUMO) stake by 8% in Q4 2016, buying an estimated $9.13K and bringing the position to 1,095 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

BlackRock Group first reported a position in LUMO in Q1 2014 and has held it in 12 quarters since. The position peaked at $299K in Q4 2015. 122 funds tracked by Wall St. Rank hold LUMO as of Q4 2016.

  • BlackRock Group held 1,095 shares of Lumos Pharma, Inc. Common Stock worth $102K as of Q4 2016.
  • BlackRock Group bought 81 Lumos Pharma, Inc. Common Stock shares in Q4 2016, an estimated $9.13K.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2828 holding.
  • BlackRock Group first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2014 and has held it in 12 quarters since.
  • BlackRock Group's Lumos Pharma, Inc. Common Stock position peaked at $299K in Q4 2015.
  • 122 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.